Who stopped the research of several drugs against COVID-19

The world health organization (who) announced the termination of clinical trials of hydroxychloroquine and the combination of lopinavir/ritonavir in the treatment of coronavirus infection. The decision was made in accordance with the recommendation of the international coordinating Committee of the so-called studies of solidarity, which is devoted to the study of experimental methods of treatment COVID-19, reported on the who website.

According to the conclusion of the coordinating Committee, the use of hydroxychloroquine or a combination of lopinavir/ritonavir compared with standard therapy actually reduces mortality among hospitalized patients with COVID-19 patients. This conclusion was made based on the available data of clinical trials data treatment methods.

In addition, several studies revealed problems of security, which also affirmed the need to end further studies of hydroxychloroquine and the combination of lopinavir/ritonavir.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]